Valuation : DUCAT VENTURES

Market Cap 61.46L 83.25L 71.64L 67.46L 1.15Cr 79Cr 1.15Cr 7.99Cr 3.09Cr 40Cr 3.13Cr 3.06Cr 127.86Cr P/E 2024
-9.76x
P/E 2025 -1.76x
Enterprise Value 51.09L 69.21L 59.55L 56.08L 95.6L 66Cr 95.98L 6.65Cr 2.57Cr 34Cr 2.6Cr 2.54Cr 106.29Cr EV / Sales 2024
19.4x
EV / Sales 2025 5.09x
Free-Float
88.62%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 66 05/08/2014
Director of Finance/CFO 65 01/11/2024
Chief Tech/Sci/R&D Officer 53 -
Director TitleAgeSince
Director/Board Member 53 04/07/2018
Director/Board Member 66 05/08/2014
Chairman 75 01/01/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%-0.71%+45.60%+103.25% 6.92TCr
-0.07%-3.93%+32.54%+78.50% 6.3TCr
+3.13%+1.71%-12.50%+390.48% 2.73TCr
-2.99%-6.71%+25.80%+10.77% 2.58TCr
-0.54%-5.47%-3.88%-18.31% 2.48TCr
-1.43%-1.89%+21.32%-19.01% 2.01TCr
-4.27%+3.07%+211.22%+362.48% 1.85TCr
-1.54%-4.59%-5.29%+506.91% 1.49TCr
+1.14%-0.34%+52.38%+163.82% 1.43TCr
Average -0.84%-0.80%+40.80%+175.43% 3.09TCr
Weighted average by Cap. -0.69%-1.32%+37.56%+139.53%

Financials

2024 2025
Net sales 9L 11.78L 10.14L 10L 16.28L 11Cr 16.34L 1.13Cr 43.74L 5.71Cr 44.25L 43.29L 18Cr 11.66L 15.79L 13.59L 12.8L 21.82L 15Cr 21.9L 1.52Cr 58.62L 7.66Cr 59.31L 58.02L 24Cr
Net income -18.05L -24.45L -21.04L -19.81L -33.77L -23Cr -33.91L -2.35Cr -90.74L -12Cr -91.81L -89.81L -38Cr -38.9L -52.69L -45.34L -42.69L -72.78L -50Cr -73.07L -5.06Cr -1.96Cr -26Cr -1.98Cr -1.94Cr -81Cr
Net Debt -7L -10.01L -9L -8L -13.83L -9.53Cr -13.88L -96.12L -37.15L -4.85Cr -37.59L -36.77L -15Cr -10.37L -14.05L -12.09L -11.38L -19.4L -13Cr -19.48L -1.35Cr -52.13L -6.81Cr -52.74L -51.6L -22Cr
Logo DUCAT VENTURES
OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!